Monday, 20 June 2016

Regulatory Affairs 2016

About Conference

Conference Series LLC is a renowned organization that organizes highly notable 
pharmaceutical conferences throughout the globe. After a successful conference of RegulatoryAffairs 2015Conference Series LLC is currently bringing forth "6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs & IPR” (Regulatory Affairs 2016) slated on September 29-30, 2016 at Orlando, USA.
Conference Series LLC invites all the participants across the globe to attend the "6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs & IPR (Regulatory Affairs 2016) slated on September 29-30, 2016 at Orlando, USA. Regulatory Affairs 2016 provides the perfect one-stop resource with the information and knowledge resources to help you develop skills and learn proven strategies and techniques to help you overcome the challenges you face in the Regulatory profession.
  • The global revenue for advanced drug delivery systems is estimated to be $151.3 billion in 2013. In 2018, revenues are estimated to reach nearly $173.8 billion, demonstrating a compound annual growth rate (CAGR) of 2.8%.
  • Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion. BCC expects this market to grow to $49 billion by 2016 at a CAGR of 5.6%
  • The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.
2016 Highlights:
  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings
Why Should I Attend?
  • Novel approaches about the drug delivery systems development and industrializing insights & gain the latest technologies about novel drug delivery systems and applications
  • Meeting with 50+ industrial experts, 50+ academic speakers, 50+Pharmaceutical Companies, 120+decision-makers interacting
  • Finding novel opportunities of doing NDDS business and dynamically providing the “value addition” to pharmaceutical R&D businesses
  • Bridging the gap between Academia and Industry in novel research methods of DDS
  • Emphasis on novel strategies for formulation and drug delivery system’s latest updates to drive your market share accordingly
  • Learn on the applications of novel DDS for treating major diseases to progress the drug portfolio industrialization pathways
Who Should Attend?
Pharmaceutical, biotech, CRO, diagnostic and academic professionals specializing in:
  • Drug Delivery
  • Product Development
  • Formulation / Pre-Formulation
  • Structure and Informatics
  • Pharmaceutical Development
  • Technology Assessment
  • PK / PD
  • Medicinal Chemistry
  • Licensing
  • Outsourcing
  • Partnering / Alliance Management
  • Regulatory Affairs
  • Lifecycle Management
  • External Manufacturing

Conference Highlights

  • Regulatory Affairs
  • Regulatory & Pharmacovigilance
  • Clinical Affairs & Regulatory Strategies
  • Regulatory Cooperation and Reliance
  • Pharmaceutical Regulatory Environment
  • Regulation and Global Regulatory Affairs
  • Biologics and Biosimilars
  • Best Industry Practices
  • Intellectual Property Rights
  • Marketing Authorizations-Affordable Healthcare and Fair Trade
  • Medical Device & Combination Products Regulations
  • Regulatory Strategies and Developments
  • Regulatory Requirements for Pharmaceuticals
  • Entrepreneurs Investment Meet

Special Issues

  •  All accepted abstracts will be published in respective OMICS   International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.